In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited.

Slides:



Advertisements
Similar presentations
Basic coagulation techniques and Quality control issues
Advertisements

General Approach in Investigation of Haemostasis
General Approach of Haemostasis
Pre-analytical factors that can affect coag test results
General Approach of Haemostasis
Quantitative Fibrinogen Mr. Mohammed A. Jaber.  Fibrinogen assays are quantitative techniques to measure the amount of functional fibrinogen present.
Coagulation Time Tube Method Mr. Mohammed A. Jaber.
Bleeding time,clotting time, PT, and PTT
Dr msaiem Acquired Coagulation Disorders Dr Mohammed Saiem Al-dahr KAAU Faculty of Applied Medical Sciences.
Week 6: Secondary Hemostasis Plasmatic factors Plasmatic factors Intrinsic pathway Intrinsic pathway Extrinsic pathway Extrinsic pathway Specimen Specimen.
MLAB 1227: C OAGULATION K ERI B ROPHY - M ARTINEZ Secondary Hemostasis Part Three.
General Approach in Investigation of Haemostasis
One Stage Factor V Assay
Coagulation Time of whole blood
LABORATORY ASPECTS OF HAEMATOLOGICAL COAGULATION.
Hemostasis and Blood Coagulation
MLAB Coagulation Keri Brophy-Martinez
Tests for the Evaluation of Lupus Anticoagulants Islamic University of Gaza.
General Approach of Haemostasis
Methods to Detect Red Cell Membrane Disorders
Secondary Hemostasis Part One MLAB Coagulation Keri Brophy-Martinez.
©2007 Wortham Laboratories, Inc.
Erythrocyte Count Normal ranges:
MIXING STUDIES General Approach of Haemostasis
MLAB 1227-Coagulation Keri Brophy-Martinez Preanalytical Issues in Coagulation Testing.
  The prothrombin time is therefore the time required for the plasma to clot after an excess of thromboplastin and an optimal concentration of calcium.
Blood Groups Clotting Time and Bleeding Time. Aims of the Practical To determine: 1.Blood groups. 2.Clotting time. 3.Bleeding time.
Investigation of Haemostasis MS. c. program Lab-9.
To understand blood coagulation tests it is helpful to have a basic understanding of the role of the different blood clotting factors and the coagulation.
Activated Partial Thromboplastin Time (aPTT)
Laboratory Testing in Coagulation Coagulation Keri Brophy-Martinez.
Factor Assays Robert Gosselin MT (ASCP), CLS.
Intrinsic pathway Extrinsic pathway Common pathway The extrinsic pathway was required the addition of an exogenous trigger (originally provided by tissue.
Bleeding time BLEEDING TIME: the time that elapses between the puncture of the skin and the stoppage of blood oozing using a lancet. Why Do I Need a Bleeding.
Hemostasis Is a complex process which causes the bleeding process to stop. It refers to the process of keeping blood within a damaged blood vessel. Dependent.
Coagulation tests CBC- complete blood count
Bleeding time It is the time that elapses between the puncture of the skin and the stoppage of blood oozing.
Chapter 17 Coagulation Testing
Hematology Unit 2 Chapter 7 Sample Collection and Handling Copyright © 2015 by Mosby, an imprint of Elsevier Inc. All rights reserved.
Bleeding Tendency Dr. Mervat Khorshied Ass. Prof. of Clinical and Chemical Pathology.
Platelets. Fig Hemostasis the process by which the bleeding is stopped from broken vessels. steps involved: Vascular spasm. Platelets plug formation.
One-Stage Quantitative
General Approach in Investigation of Hemostasis
MLAB Coagulation Keri Brophy-Martinez
Bleeding Disorders Last update
Activated Partial Thromboplastin Time (aPTT)
General Approach of Haemostasis
General Approach in Investigation of Hemostasis
One Stage Factor V Assay
General Approach of Haemostasis
General Principles of Hemostasis Kristine Krafts, M.D.
General Approach in Investigation of Hemostasis
Tests for hemostasis (Practical)
Methods to Detect Red Cell Membrane Disorders
Mixing Studies-aPTT or PT 1:1 Mix
Steps in clotting mechanism
Activated Partial Thromboplastin Time (aPTT)
How to Interpret and Pursue an Abnormal Prothrombin Time, Activated Partial Thromboplastin Time, and Bleeding Time in Adults  Arif H. Kamal, MD, Ayalew.
Intrinsic pathway Formation of prothombin activator is the central event in the clotting pathway For its formation the pathway that is initiated by.
Coagulation Factor Assays
General Principles of Hemostasis Kristine Krafts, M.D.
Practical Hematology Lab Osmotic Fragility Test
General Approach in Investigation of Hemostasis
Principles of Coagulation Screening II
General Approach in Investigation of Hemostasis
Practical Hematology Lab Osmotic Fragility Test
Blood Physiology.
Practical Hematology Lab Osmotic Fragility Test
Practical Blood Bank Lab 11 Cyroglobulin.
Presentation transcript:

In this exercise, two tests will be performed to screen for defective clotting factors. The formation of thrombin in the plasma samples will be inhibited by an anticoagulant. The anticoagulant used, either citric acid or oxalic acid, removes calcium ion (Ca2+) from the plasma. The removal of Ca2+ has an anticoagulant effect because calcium is a necessary cofactor in the activation of a number of the clotting factors. This inhibition can be easily reversed by adding calcium ion during the clotting tests.

Clotting time or Coagulation time The time required for blood to clot in a glass tube. The normal range for the test described below is 5 to 15 min. but each laboratory should determine its own normal values. Reagent & equipment water bath, 37C. Glass test tube. Stopwatch. Plastic syringe and 20-gauge needle. Specimen: fresh whole blood , 4 ml .

Procedure Label 3 glass test tube with patient name and number them, #1, #2, and #3. Add 1 ml of blood in each tube. The last 1 mL of blood may be discarded. Start the stopwatch as soon as the blood is placed in tube #3. Place the three test tubes in a 37°C water bath. At exactly 5 min., title test tube #1 gently to a 45° angle. Repeat this procedure every 30 seconds, until the test tube can be completely inverted without spilling the contents (that is, until the blood is completely clotted).

Record the time it took the blood in test tube #1 to clot. 30 sec. after the blood in test tube #1 is clotted. Proceed with tube #2, and repeat the preceding procedure, tilting the test tube every 30 seconds, until a clot is formed. Record the results. Repeat this procedure for test tube #3.

Clotting time - capillary method Material Sterile disposable pricking needle or lancet. Stop watch Dry glass capillary tube (narrow diameter 1 top 2 mm, minimum 10 cm long.) Cotton Swab of absorbent cotton. Spirit wetted, cotton swab. 70 % v/v ethyl alcohol

Clotting time of whole blood

Clotting Time - Slide Method The surface of the glass tube initiates the clotting process. This test is sensitive to the factors involved in the intrinsic pathway The expected range for clotting time is 4-10 min.

Terms Why is PPP essential? Platelet –Poor plasma (PPP) <10 x 10 9 /L. Why is PPP essential? Contains platelet factor 4(heparin neutralizer). Contains phospholipid (affects lupus anticoagulant and factor assay testing). Contains proteases (affect testing for vWF). Platelet-Rich plasma (PRP) 200-300 x 10 9 /L.

PT Reagent Calcium ions and Thromboplastin from brain tissue (Rabbit). Thromboplastin (Tissue Factor) protein-lipid complex found in tissues outside blood vessels.

Principle The procedure uses a tissue thromboplastin reagent with CaCL (Calcium Chloride) to provide a one step procedure for evaluating plasma clotting. The normal values for the prothrombin time range from 10.0 to 13.0 seconds. An elevated prothrombin time may indicate the presence of Vitamin K deficiency, DIC, liver disease, Presence of FSP’s

Performing a PT test Pre-warm PT reagent and sample to 37 oC Add 100 L sample to tube Add 200 L of PT reagent to tube Start timer Record time to clot in seconds If the results from run 1 and run 2 are within + 1 second from each other, average the two results and report with appropriate units. If results are not within required limits, a third run should be performed and average the two that match within acceptable limits. Calculate INR

Expected PT Values Mean Normal Plasma = 10 to 14 seconds. A high sensitivity (Low ISI) PT will give a high normal PT value (13 to 15 seconds). Oral anticoagulant monitoring = Target INR of 2.0 to 3.0. INR of greater than 5 or 5.5 = unacceptable high risk of bleeding.

PTT Reagents Phospholipids and a surface activator Calcium Chloride reagent added to start the reaction. APTT reagent mimics the surface of a platelet.

Principle Under carefully controlled conditions and with properly prepared reagents, calcium, partial thromboplastin and an activator (such as kaolin, celite, micronized silica or ellagic acid) are added to the plasma to be tested, which eliminates the variability of activation by glass contect. The partial thromboplastin reagent stimulates activated platelet surfaces by providing a phospholipid platelet surface on which enzymatic reactions can occur. which eliminates the test’s sensitivity to platelet number and function.

Sample Citrate tube; 3.2% citrate tubes Ratio of anticoagulant to blood should be 1:9 After centrifugation, the Plasma contains all the intrinsic coagulation factors except calcium (removed during anticoagulation) and the platelets (removed during centrifugation).

Procedure Prewarm sufficient volumes of CaCl2 (0.025 M) to 37oC Label 2 test tube & 2 control tubes Add 0.1 ml (100µL) of sample or control to the appropriate tube Add 0.1 ml of APTT reagent to each tube Incubate at 37oC for 5 minutes Add 0.1 ml (100µL) of prewarmed CaCl2 & start stop watch immediately Record the time at which clot is detected

Expected APTT Values Normal Range: 25 to 43 seconds Slightly Elevated: 45 to 65 seconds Extremely Elevated > 70 seconds

What does the test result mean? APTT prolongations are caused by either factor deficiencies (especially of factors VIII, IX, XI, and/or XII), Inhibitors (most commonly, lupus anticoagulants{ immunoglobulin that binds to phospholipids and proteins associated with the cell membrane}) Therapeutic anticoagulants such as heparin. DIC Liver disease

Sources of error Associated with specimen Inappropropriate ratio of anticoagulant to blood Failure to correct citrate volume if hematocrit > 55% Clotted, hemolyzed or lipemic samples Lack of PPP

3. Associated with procedure 2. Associated with reagent Incorrect preparation of reagents Failure to properly store reagents Use of reagents beyond reconstituted stability time or expiration date Contaminated reagents 3. Associated with procedure Incorrect temperature Incorrect incubation times Incorrect volumes of sample, reagents or both

Defective Factor PT APTT V Abnormal VII Normal VIII IX X XI XII